NB
Nizar Jacques Bahlis
Hematology & Oncology
Credentials: ·
Research
Ide-cel or Standard Regimens in Relapsed and Refractory Multiple Myeloma
New England Journal of Medicine · 2023 · 653 citations
Elranatamab in relapsed or refractory multiple myeloma: phase 2 MagnetisMM-3 trial results
Nature Medicine · 2023 · 572 citations
Mechanisms of antigen escape from BCMA- or GPRC5D-targeted immunotherapies in multiple myeloma
Nature Medicine · 2023 · 311 citations
Saad Usmani
23 papers
15 papers
13 papers
12 papers
12 papers
- RK
10 papers
7 papers
- DS
7 papers
